Back to search

University of British Columbia

Examining the effect of short-term oral ketone supplementation on markers of NLRP3 inflammasome activation in individuals with obesity

Abstract

dc:description

Background: The NLRP3 inflammasome, an innate immune sensor, has been implicated in the progression in a number of chronic inflammatory diseases and represents an important therapeutic target. The ketone body, beta-hydroxybutyrate (BHB) has been shown to attenuate NLRP3 activation in murine and in vitro models. However, these findings have not yet been replicated in humans. Methods: We conducted a randomized, double-blind, placebo-controlled, crossover study in humans with obesity (N = 14). We tested the hypothesis that elevation of blood BHB by ingestion of an exogenous ketone monoester drink (KME) 3x/day for 14 days would attenuate basal NLRP3 activation and would reduce NLRP3 sensitivity to activation in response to an inflammatory challenge. NLRP3 activation was quantified by magnitude of caspase-1 activation and secreted IL-1b. We also conducted an exploratory in vitro experiment in parallel to the in vivo study in which whole blood from each participant was cultured with lipopolysaccharide (LPS) and increasing concentrations of BHB. Results: KME supplementation elevated blood BHB concentration to ~2 mM. Monocyte caspase-1 activation was reduced in response to an inflammatory stimulus following 14-days of KME compared to placebo (time x condition interaction, χ²(1)=3.80, P = 0.05). Similarly, low-to-moderate, but not high, concentrations of BHB in culture appeared to attenuate IL-1b secretion in a dose-dependent manner. However, basal caspase-1 activation and plasma cytokines remained unchanged. Conclusions: Fourteen days of KME, which elevates BHB to low-to-moderate levels, appears to attenuate NLRP3 activation in human monocytes exposed to an inflammatory stimulus. This is the first study to replicate this concept in an in vivo/ex vivo human model. Future research should investigate the potential therapeutic effect of KME in human disease that exhibit excessive NLRP3 activation.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Health and Exercise Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Neudorf, Helena

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/74735

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Neudorf, Helena. Examining the effect of short-term oral ketone supplementation on markers of NLRP3 inflammasome activation in individuals with obesity. master's thesis, University of British Columbia, 2020. http://hdl.handle.net/2429/74735